These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3290292)

  • 21. Dermal injection of immunocytes induces psoriasis.
    Wrone-Smith T; Nickoloff BJ
    J Clin Invest; 1996 Oct; 98(8):1878-87. PubMed ID: 8878440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increase of circulating HLA DR+ T lymphocytes in psoriasis].
    Paciel J; Vignale RA; Bruno J; Vázquez G; De Anda G
    Med Cutan Ibero Lat Am; 1984; 12(6):497-500. PubMed ID: 6397671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy.
    Vallat VP; Gilleaudeau P; Battat L; Wolfe J; Nabeya R; Heftler N; Hodak E; Gottlieb AB; Krueger JG
    J Exp Med; 1994 Jul; 180(1):283-96. PubMed ID: 7516410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation.
    Gottlieb AB; Grossman RM; Khandke L; Carter DM; Sehgal PB; Fu SM; Granelli-Piperno A; Rivas M; Barazani L; Krueger JG
    J Invest Dermatol; 1992 Mar; 98(3):302-9. PubMed ID: 1372027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasis.
    Morhenn VB; Orenberg EK; Kaplan J; Pfendt E; Terrell C; Engleman EG
    J Invest Dermatol; 1983 Jul; 81(1):23-7. PubMed ID: 6863976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: combined effects on epidermal and immunologic activation.
    Hodak E; Gottlieb AB; Segal T; Politi Y; Maron L; Sulkes J; David M
    J Am Acad Dermatol; 2003 Sep; 49(3):451-7. PubMed ID: 12963909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions.
    Terui T; Aiba S; Kato T; Tanaka T; Tagami H
    Br J Dermatol; 1987 Jan; 116(1):87-93. PubMed ID: 2434124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of dendritic cells in the immunopathogenesis of psoriasis.
    Jariwala SP
    Arch Dermatol Res; 2007 Oct; 299(8):359-66. PubMed ID: 17680257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DR antigen expression in tonsillar epithelium. With special reference to focal infection.
    Kimura T; Fujiwara K; Kuki K; Hayashi Y; Tabata T
    Acta Otolaryngol; 1990; 110(5-6):459-65. PubMed ID: 2284921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.
    Shen Z; Wang G; Fan JY; Li W; Liu YF
    J Dermatol Sci; 2005 Apr; 38(1):25-39. PubMed ID: 15795121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed epidermal cell lymphocyte reaction: HLA-DR+ cells exhibit a greater immunostimulatory activity than CD1a+ cells.
    Dobmeyer TS; Dobmeyer JM; Klein SA; Schopf RE; Helm EB; Rossol R
    Adv Exp Med Biol; 1995; 378():393-6. PubMed ID: 8526102
    [No Abstract]   [Full Text] [Related]  

  • 34. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
    Abrams JR; Kelley SL; Hayes E; Kikuchi T; Brown MJ; Kang S; Lebwohl MG; Guzzo CA; Jegasothy BV; Linsley PS; Krueger JG
    J Exp Med; 2000 Sep; 192(5):681-94. PubMed ID: 10974034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes?
    Komine M; Karakawa M; Takekoshi T; Sakurai N; Minatani Y; Mitsui H; Tada Y; Saeki H; Asahina A; Tamaki K
    J Invest Dermatol; 2007 Aug; 127(8):1915-22. PubMed ID: 17446902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro. Involvement of ATPase, HLA-DR, B7 molecules, and cytokines.
    Schempp CM; Dittmar HC; Hummler D; Simon-Haarhaus B; Schulte-Mönting J; Schöpf E; Simon JC
    J Invest Dermatol; 2000 Oct; 115(4):680-6. PubMed ID: 10998143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.
    Travers JB; Hamid QA; Norris DA; Kuhn C; Giorno RC; Schlievert PM; Farmer ER; Leung DY
    J Clin Invest; 1999 Nov; 104(9):1181-9. PubMed ID: 10545517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
    Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
    Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infiltration of T Cells into a Three-Dimensional Psoriatic Skin Model Mimics Pathological Key Features.
    Lorthois I; Simard M; Morin S; Pouliot R
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical calcipotriol for psoriasis--an immunohistologic study.
    Mozzanica N; Cattaneo A; Schmitt E; Diotti R; Finzi AF
    Acta Derm Venereol Suppl (Stockh); 1994; 186():171-2. PubMed ID: 7915481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.